Kapitel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
2. Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines
-
Rajat Khosla
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Kapitel in diesem Buch
- Frontmatter i
- Contents v
- Acknowledgments vii
- 1.Introduction: Access to Medicines as a Human Right - What Does It Mean for Pharmaceutical Industry Responsibilities? 1
-
PART ONE. Rights, Norms, and Ethics
- 2. Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines 25
- 3. Improving Access to Essential Medicines: International Law and Normative Change 46
- 4. Corporate Social Responsibility and the Right to Essential Medicines 75
-
PART TWO. Social versus Business Responsibilities
- 5. Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility 93
- 6. Social Responsibility and Marketing of Drugs in Developing Countries: A Goal or an Oxymoron? 125
-
PART THREE. Case Studies for Achieving Corporate Responsibility
- 7. Managing the Market for Medicines Access: Realizing the Right to Health by Facilitating Compulsory Licensing of Pharmaceuticals - A Case Study of Legislation and the Need for Reform 151
- 8. Ubuntu, AIDS, and the King II Report: Reflections on Corporate Social Responsibility in South Africa 179
- Annex: Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines 197
- Contributors 213
Kapitel in diesem Buch
- Frontmatter i
- Contents v
- Acknowledgments vii
- 1.Introduction: Access to Medicines as a Human Right - What Does It Mean for Pharmaceutical Industry Responsibilities? 1
-
PART ONE. Rights, Norms, and Ethics
- 2. Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines 25
- 3. Improving Access to Essential Medicines: International Law and Normative Change 46
- 4. Corporate Social Responsibility and the Right to Essential Medicines 75
-
PART TWO. Social versus Business Responsibilities
- 5. Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility 93
- 6. Social Responsibility and Marketing of Drugs in Developing Countries: A Goal or an Oxymoron? 125
-
PART THREE. Case Studies for Achieving Corporate Responsibility
- 7. Managing the Market for Medicines Access: Realizing the Right to Health by Facilitating Compulsory Licensing of Pharmaceuticals - A Case Study of Legislation and the Need for Reform 151
- 8. Ubuntu, AIDS, and the King II Report: Reflections on Corporate Social Responsibility in South Africa 179
- Annex: Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines 197
- Contributors 213